Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/umeclidinium/vilanterol Phase 3 trial in Japan
jRCT2080223736Phase 3Completed
- Start
- Nov 2017
- Modality
- Small Molecules
01
Overview
Phase 3 trial of fluticasone furoate + umeclidinium bromide + vilanterol trifenatate in Chronic Respiratory Disease (CRD) (2 arms). Started Nov 2017; status: completed.
02
Drugs
fluticasone furoate + umeclidinium bromide + vilanterol trifenatate
03
Conditions
Chronic Respiratory Disease (CRD)
Beyond the preview
Go deeper on jRCT2080223736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223736.